What is MiRus?
Founded in 2015 and headquartered in Marietta, Georgia, MiRus is a medical device company focused on addressing critical needs in spine, orthopedics, and cardiovascular disease. The company has developed a unique integrated platform that encompasses pre-operative planning and risk assessment tools, innovative procedural solutions, and post-operative monitoring and risk mitigation software. MiRus's proprietary novel biomaterials and implants are designed to meet the evolving demands of the modern healthcare environment, aiming to improve patient outcomes and streamline clinical workflows.
How much funding has MiRus raised?
MiRus has raised a total of $66M across 2 funding rounds:
Debt
$1M
Unspecified
$65M
Debt (2020): $1M with participation from PPP
Unspecified (2021): $65M led by Mammoth Scientific
Key Investors in MiRus
Mammoth Scientific
Mammoth Scientific is an investor participating in the company's funding rounds. Further details on their investment focus are not publicly available.
PPP
Public-Private Partnership
What's next for MiRus?
The substantial enterprise-level funding and recent strategic investment position MiRus for accelerated growth and market penetration. This capital infusion is expected to fuel further research and development, enhance manufacturing capabilities, and expand the company's commercial reach. MiRus's focus on an integrated platform suggests a strategy aimed at capturing a significant share of the medical device market by offering comprehensive solutions rather than standalone products. The company's trajectory indicates a move towards scaling its established technologies and potentially exploring new therapeutic areas or advanced applications.
See full MiRus company page
